Covid 19 Screening of Chinese travelers assessed quotunjustifiedquot through the

Covid 19: Screening of Chinese travelers assessed "unjustified" through the EU

Published on: 2022-12-29 – 17:18

The reopening of borders in China amid the outbreak of the Covid-19 epidemic is a concern for several states, including the United States, which will require Chinese travelers to be tested negatively upon arrival in the country. For its part, however, the European Center for Disease Prevention and Control (ECDC) considered this measure “unjustified” in the European Union.

The introduction of mandatory screening for Covid-19 within the European Union for travelers arriving from China – which is experiencing a blast in cases – is “unjustified”, the European Center for Disease Prevention and Disease Control (ECDC) estimated on Thursday, April 29. December.

EU countries “have relatively high levels of immunization and vaccination” and “variants circulating in China are already circulating in the EU,” ECDC said in a statement, explaining that such action should be taken at the level of the European Union is not necessary, since this is not necessary a whole.

>> In view of the outbreak of Covid-19 in China, the fear of the impact in Europe

Healthcare systems that can “manage” the disease

For the European Agency, “the potential infections” that can be imported are “rather small” compared to the number of infections already circulating every day. Health systems “now have the capacity to cope with the disease,” she added.

The European Commission convened a meeting on Thursday to discuss “possible measures for a coordinated approach” by EU countries to the explosion of Covid cases in China. Several countries, including Italy or Japan, as well as the United States, have already decided to impose mandatory tests on all travelers coming from China.

The abrupt end this month of China’s “zero Covid” policy, designed to encourage Chinese people to resume overseas travel, came as the country faced the world’s biggest wave of infections, compounded by the emergence of new variants.

With AFP